Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1996 Dec;89(4):592–598. doi: 10.1046/j.1365-2567.1996.d01-785.x

Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.

J Fleischer 1, E Soeth 1, N Reiling 1, E Grage-Griebenow 1, H D Flad 1, M Ernst 1
PMCID: PMC1456589  PMID: 9014827

Abstract

The interaction of CD28 with its ligands is important for T-cell activation. Recent studies demonstrated the existence of at least two ligands on accessory cells, CD80 (B7-1) and CD86 (B7-2). In this study we demonstrate that, although CD80 and CD86 are both expressed on monocytes, they seem to have different functions. Freshly isolated monocytes express CD86 but are CD80-negative. CD80 expression is weakly induced after 6-8 hr of in vitro culture and is enhanced by stimulation. CD86 expression is enhanced faster than CD80 expression and reaches the peak level after 4-6 hr in stimulated cells. Reverse transcription-polymerase chain reaction studies demonstrate that freshly isolated monocytes contain no CD80-mRNA. The mRNA of CD80 is induced after 4-6 hr of culture, which matches with the expression of the protein. Inhibition studies using different antibodies against both molecules and the fusion protein CTLA4Ig show that only anti-CD80 and CTLA4Ig could partially inhibit antigen-specific (tuberculin) and polyclonal (anti-CD3) lymphoproliferation and interferon-gamma (IFN-gamma) secretion of T cells cocultured with autologous monocytes. IFN-gamma secretion was more sensitive to blocking costimulation than proliferation. The antibody BB-1 did not inhibit proliferation and cytokine secretion, nor did the anti-CD86 clone IT2.2. CTLA4Ig, which binds both CD80 and CD86, has the same inhibitory capacity as the anti-CD80 antibody tested. From those findings we conclude that human monocytes use CD80 as a costimulatory ligand for CD28 and utilize other costimulatory mechanisms besides those mediated via molecules of the B7 family.

Full text

PDF
592

Images in this article

595Figure 3
on p.595

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Augustin M., Dietrich A., Niedner R., Kapp A., Schöpf E., Ledbetter J. A., Brady W., Linsley P. S., Simon J. C. Phorbol-12-myristate-13-acetate-treated human keratinocytes express B7-like molecules that serve a costimulatory role in T-cell activation. J Invest Dermatol. 1993 Mar;100(3):275–281. doi: 10.1111/1523-1747.ep12469748. [DOI] [PubMed] [Google Scholar]
  2. Azuma M., Ito D., Yagita H., Okumura K., Phillips J. H., Lanier L. L., Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature. 1993 Nov 4;366(6450):76–79. doi: 10.1038/366076a0. [DOI] [PubMed] [Google Scholar]
  3. Barcy S., Wettendorff M., Leo O., Urbain J., Kruger M., Ceuppens J. L., de Boer M. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity. Int Immunol. 1995 Feb;7(2):179–189. doi: 10.1093/intimm/7.2.179. [DOI] [PubMed] [Google Scholar]
  4. Caux C., Vanbervliet B., Massacrier C., Azuma M., Okumura K., Lanier L. L., Banchereau J. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med. 1994 Nov 1;180(5):1841–1847. doi: 10.1084/jem.180.5.1841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Engel P., Gribben J. G., Freeman G. J., Zhou L. J., Nozawa Y., Abe M., Nadler L. M., Wakasa H., Tedder T. F. The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen. Blood. 1994 Sep 1;84(5):1402–1407. [PubMed] [Google Scholar]
  6. Freedman A. S., Freeman G. J., Rhynhart K., Nadler L. M. Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol. 1991 Oct 15;137(2):429–437. doi: 10.1016/0008-8749(91)90091-o. [DOI] [PubMed] [Google Scholar]
  7. Freeman G. J., Borriello F., Hodes R. J., Reiser H., Hathcock K. S., Laszlo G., McKnight A. J., Kim J., Du L., Lombard D. B. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science. 1993 Nov 5;262(5135):907–909. doi: 10.1126/science.7694362. [DOI] [PubMed] [Google Scholar]
  8. Gallati H. Interferon: Wesentlich vereinfachte, enzym-immunologische Bestimmung mit zwei monoklonalen Antikörpern. J Clin Chem Clin Biochem. 1982 Dec;20(12):907–914. [PubMed] [Google Scholar]
  9. Geppert T. D., Lipsky P. E. Activation of T lymphocytes by immobilized monoclonal antibodies to CD3. Regulatory influences of monoclonal antibodies to additional T cell surface determinants. J Clin Invest. 1988 May;81(5):1497–1505. doi: 10.1172/JCI113481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Girolomoni G., Zambruno G., Manfredini R., Zacchi V., Ferrari S., Cossarizza A., Giannetti A. Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level. J Invest Dermatol. 1994 Jul;103(1):54–59. doi: 10.1111/1523-1747.ep12389619. [DOI] [PubMed] [Google Scholar]
  11. Grage-Griebenow E., Lorenzen D., Fetting R., Flad H. D., Ernst M. Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur J Immunol. 1993 Dec;23(12):3126–3135. doi: 10.1002/eji.1830231213. [DOI] [PubMed] [Google Scholar]
  12. Johnson J. G., Jenkins M. K. Monocytes provide a novel costimulatory signal to T cells that is not mediated by the CD28/B7 interaction. J Immunol. 1994 Jan 15;152(2):429–437. [PubMed] [Google Scholar]
  13. Linsley P. S., Brady W., Grosmaire L., Aruffo A., Damle N. K., Ledbetter J. A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med. 1991 Mar 1;173(3):721–730. doi: 10.1084/jem.173.3.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Linsley P. S., Brady W., Urnes M., Grosmaire L. S., Damle N. K., Ledbetter J. A. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med. 1991 Sep 1;174(3):561–569. doi: 10.1084/jem.174.3.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Linsley P. S., Ledbetter J. A. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol. 1993;11:191–212. doi: 10.1146/annurev.iy.11.040193.001203. [DOI] [PubMed] [Google Scholar]
  16. McLellan A. D., Starling G. C., Williams L. A., Hock B. D., Hart D. N. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule. Eur J Immunol. 1995 Jul;25(7):2064–2068. doi: 10.1002/eji.1830250739. [DOI] [PubMed] [Google Scholar]
  17. Mitra R. S., Judge T. A., Nestle F. O., Turka L. A., Nickoloff B. J. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J Immunol. 1995 Mar 15;154(6):2668–2677. [PubMed] [Google Scholar]
  18. Nickoloff B. J., Mitra R. S., Lee K., Turka L. A., Green J., Thompson C., Shimizu Y. Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo. Am J Pathol. 1993 Apr;142(4):1029–1040. [PMC free article] [PubMed] [Google Scholar]
  19. Nickoloff B. J., Nestle F. O., Zheng X. G., Turka L. A. T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28. Blood. 1994 May 1;83(9):2580–2586. [PubMed] [Google Scholar]
  20. Rattis F. M., Péguet-Navarro J., Staquet M. J., Dezutter-Dambuyant C., Courtellemont P., Redziniak G., Schmitt D. Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells. Eur J Immunol. 1996 Feb;26(2):449–453. doi: 10.1002/eji.1830260227. [DOI] [PubMed] [Google Scholar]
  21. Reiling N., Ulmer A. J., Duchrow M., Ernst M., Flad H. D., Hauschildt S. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol. 1994 Aug;24(8):1941–1944. doi: 10.1002/eji.1830240836. [DOI] [PubMed] [Google Scholar]
  22. Schwartz R. H., Mueller D. L., Jenkins M. K., Quill H. T-cell clonal anergy. Cold Spring Harb Symp Quant Biol. 1989;54(Pt 2):605–610. doi: 10.1101/sqb.1989.054.01.072. [DOI] [PubMed] [Google Scholar]
  23. Selvakumar A., Mohanraj B. K., Eddy R. L., Shows T. B., White P. C., Dupont B. Genomic organization and chromosomal location of the human gene encoding the B-lymphocyte activation antigen B7. Immunogenetics. 1992;36(3):175–181. doi: 10.1007/BF00661094. [DOI] [PubMed] [Google Scholar]
  24. Thanhäuser A., Reiling N., Böhle A., Toellner K. M., Duchrow M., Scheel D., Schlüter C., Ernst M., Flad H. D., Ulmer A. J. Pentoxifylline: a potent inhibitor of IL-2 and IFN-gamma biosynthesis and BCG-induced cytotoxicity. Immunology. 1993 Sep;80(1):151–156. [PMC free article] [PubMed] [Google Scholar]
  25. Weiss J. M., Renkl A. C., Denfeld R. W., de Roche R., Spitzlei M., Schöpf E., Simon J. C. Low-dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co-stimulatory molecules on human Langerhans cells. Eur J Immunol. 1995 Oct;25(10):2858–2862. doi: 10.1002/eji.1830251022. [DOI] [PubMed] [Google Scholar]
  26. Yokochi T., Holly R. D., Clark E. A. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. J Immunol. 1982 Feb;128(2):823–827. [PubMed] [Google Scholar]
  27. Young J. W., Koulova L., Soergel S. A., Clark E. A., Steinman R. M., Dupont B. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. J Clin Invest. 1992 Jul;90(1):229–237. doi: 10.1172/JCI115840. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES